Publisher: Wiley-Blackwell

Related content
Volume 98, Supplement 19, 1 November 1990

< previous issue | all issues | next issue >

Favourites:Add to Favourites

Sponsors
pp. i-i(1)

Favourites:Add to Favourites

Dr. med. Dr. h. c. Friedrich Wegener
pp. 2-2(1)
Authors: Lehmann, H.; Andrassy, K.; Rasmussen, N.; Woude, F.; Wiik, A.

Favourites:Add to Favourites

Introduction
pp. 3-3(1)
Authors: Lehmann, H; Andrassy, K.; Rasmussen, N.; Woude, F.; Wiik, A.

Favourites:Add to Favourites

Histopathological findings in biopsies from patients with Wegener's granulomatosis
pp. 15-16(2)
Authors: Rasmussen, N.; Petersen, J.; Jensen, H.; Andersen, V.

Favourites:Add to Favourites

Histopathological differentiation of systemic necrotizing vasculitides
pp. 17-18(2)
Authors: Waldherr, R.; Eberlein‐Gonska, M.; Noronha, I. L.

Favourites:Add to Favourites

Clinical manifestations of Wegener's granulomatosis
pp. 19-20(2)
Authors: Lehmann, H.; Kiefer, B.

Favourites:Add to Favourites
Favourites:Add to Favourites

Indium leucocyte imaging in systemic vasculitis
pp. 22-22(1)
Authors: Llewelyn, M. B.; Wraight, P.; Lockwood, C. M.

Favourites:Add to Favourites

Ocular involement in Wegener's granulomatosis
pp. 22-22(1)
Authors: Duncker, G.; Coners, H.; Nölle, B.

Favourites:Add to Favourites

Spleen involvement in Wegener's granulomatosis: Two case reports
pp. 23-23(1)
Authors: Gregorini, G.; Campanini, M.; Tira, P.; Lancini, L.; Tincani, A.; Maiorca, R.

Favourites:Add to Favourites

The relation of 29 kD C‐ANCA antigen to proteinase 3
pp. 26-27(2)
Authors: Goldschmeding, R.; Dolman, K. M.; Ende, M. E.; Meer‐Gerritsen, C. H.; Sonnenberg, A.; Borne, A. E. G. Kr.

Favourites:Add to Favourites

ANCA related antigens
pp. 28-28(1)
Authors: Dolman, K. M.; Goldschmeding, R.; Sonnenberg, A.; Borne, A. E. G. Kr.

Favourites:Add to Favourites
Favourites:Add to Favourites

29 kD serineprotease, myeloperoxidase and their antibodies in renal biopsies
pp. 31-32(2)
Authors: Brouwer, E.; Tervaert, J. W. Cohen; Weening, J. J.; Kallenberg, C. G. M.

Favourites:Add to Favourites

Specificity of anti‐neutrophil cytoplasm antibodies (ANCA) in vasculitic syndromes
pp. 32-32(1)
Authors: Sinico, R. A.; Radice, A.; POZZI, C.; Italian Group of Renal Immunopathologycr4

Favourites:Add to Favourites

Anti‐myeloperoxidase antibodies in vasculitis: Relationship to ANCA and clinical diagnosis
pp. 33-33(1)
Authors: Gaskin, G.; Ryan, J. J.; Rees, A. J.; Pusey, C. D.

Favourites:Add to Favourites

Anti‐myeloperoxidase antibodies of IgG isotype in IgA nephropathy
pp. 33-33(1)
Authors: O'Donoghue, D.; Nusbaum, P.; Halbwachs‐Mercarelli, L.; Lesavre, P.

Favourites:Add to Favourites

Anti‐granulocyte antibodies in Crohn's disease
pp. 34-34(1)
Authors: Peen, E.; Tejle, K.; Skogh, T.

Favourites:Add to Favourites

Clinical and histopathological association of 29kD‐ANCA and MPO‐ANCA
pp. 35-35(1)
Authors: Tervaert, J. W. Cohen; Elema, J. D.; Kallenberg, C. G. M.

Favourites:Add to Favourites

Correlation between eye symptoms and ANCAs
pp. 36-36(1)
Authors: Nölle, B.; Coners, H.; Gross, W.‐L.; Duncker, G.

Favourites:Add to Favourites

Presence of ANCA in sera of uveitis patients
pp. 36-36(1)
Authors: Vijver‐Reenalda1, H.; Keizer, R. J. W.; Kijlstra, A.; Halma, N. C.; Daha, M. R.; Woude, F. J.

Favourites:Add to Favourites

Criteria for disease activity in Wegener's granulomatosis: A requirement for longitudinal clinical studies
pp. 37-39(3)
Authors: Kallenberg, C. G. M.; Tervaert, J. W. Cohen; Stegeman, C. A.

Favourites:Add to Favourites

The effect of immunosuppressive treatment on ANCA
pp. 40-41(2)
Authors: Petersen, J.; Rasmussen, N.

Favourites:Add to Favourites

Sequential ANCA and C‐reactive protein estimations in the management of systemic vasculitis
pp. 44-44(1)
Authors: Jayne, D. R. W.; Heaton, A.; Evans, D. B.; Lockwood, C. M.

Favourites:Add to Favourites

Treatment of Wegener's granulomatosis (WG) using ANCA titers as a therapeutic guideline: a controlled prospective study
pp. 44-44(1)
Authors: Tervaert, J. W. Cohen; Hem, G. K.; Hene, R. J.; Kallenberg, C. G. M.

Favourites:Add to Favourites

The isotype distribution of ANCA in systemic vasculitis
pp. 45-45(1)
Authors: Jayne, D. R. W.; Lockwoood, C. M.

Favourites:Add to Favourites

Predominance of IgG1‐and IgG4‐subclass in anti‐neutrophil cytoplasmic antibodies (ANCA)
pp. 45-45(1)
Authors: Brouwer, E.; Trevaert, J. W. Cohen; Horst, G.; Huitema, M. G.; Limburg, P. C.; Kallenberg, C. G. M.

Favourites:Add to Favourites

Lack of clinical symptoms despite long‐term positive ANCA in Wegener's disease (WD)
pp. 46-46(1)
Authors: Mann, J.; Sterzel, R. Bernd; Weber, M.

Favourites:Add to Favourites
Favourites:Add to Favourites

Treatment of primary systemic vasculitis
pp. 48-50(3)
Authors: Pusey, C. D.; Gaskin, G.; Rees, A. J.

Favourites:Add to Favourites

Alternative treatment strategies in Wegener's granulomatosis: First results of a prospective study
pp. 51-51(1)
Authors: Ulmer, M.; Reinhold‐Keller, E.; Gross, W. L.

Favourites:Add to Favourites

Methylprednisolone in the treatment of Wegener's granulomatosis, polyarteritis nodosa and Churg‐Strauss angiitis
pp. 52-53(2)
Authors: Guillevin, L.; Rosser, J.; Cacoub, P.; Mousson, C.; Jarrousee, B.

Favourites:Add to Favourites
Favourites:Add to Favourites

Treatment of Wegener's granulomatosis with trimethoprim‐sulfamethoxazole
pp. 61-62(2)
Authors: Rasmussen, N.; Petersen, J.; Remvig, L.; Andersen, V.

Favourites:Add to Favourites

Long‐term follow‐up in 49 patients with microscopic polyarteritis
pp. 63-63(1)
Authors: Gaskin, G.; Mason, P. D.; Bateson, K.; Evans, D. J.; Rees, A. J.; Pusey, C. D.

Favourites:Add to Favourites
Favourites:Add to Favourites
Favourites:Add to Favourites

Monoclonal antibody therapy in systemic vasculits
pp. 64-64(1)
Authors: Mathieson, P. W.; Lockwood, C. M.; Waldmann, H.

Favourites:Add to Favourites

Sulfamethoxazole‐trimethoprim (SMZ‐TMP) as an effective therapy for Wegener's granulomatosis (WG) ‐ three more cases
pp. 65-65(1)
Authors: Hoen, B.; Aymard, B.; Gerard, A.; Brunet, A.; Mertes, P. M.; May, Th.; Canton, Ph.; Dureux, J. B.

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more